Clinical Trial 40206

share

Garden Grove, CA 92845


Study Summary:

AN ADAPTIVE PHASE II/III, DOUBLE-BLIND, RANDOMIZED, PLACEBOCONTROLLED,
TWO-PART, DOSE-FINDING, MULTI-CENTER STUDY OF THE SAFETY
AND EFFICACY OF NABEN® (SODIUM BENZOATE), A D-AMINO ACID OXIDASE
INHIBITOR, AS AN ADD-ON THERAPY WITH CLOZAPINE, FOR RESIDUAL
SYMPTOMS OF REFRACTORY SCHIZOPHRENIA IN ADULTS


Qualified Participants Must:

• Male or female subjects who are between 18 and 55 years of age


Qualified Participants May Receive:

Compensation for time and travel


Study is Available At:

CNS Network
12772 Valley View Ave, Suite 3
Garden Grove, CA 92845
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.